Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CTEV Claritev Corporation

Pre-Mkt 03-05 08:24:48 EST

17.82

+0.91

+5.38%

盘前17.88

+0.06+0.34%

08:00 EST

High18.21	Low16.53	Vol262.89K
Open16.82	D1 Closing16.91	Amplitude9.93%
Mkt Cap294.49M	Tradable Cap99.38M	Total Shares16.53M
T/O4.61M	T/O Rate4.71%	Tradable Shares5.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CTEV","market":"US","secType":"STK","nameCN":"Claritev Corporation","latestPrice":17.82,"timestamp":1772658000000,"preClose":16.91,"halted":0,"volume":262886,"hourTrading":{"tag":"盘前","latestPrice":17.88,"preClose":17.82,"latestTime":"08:00 EST","volume":1,"amount":17.88,"timestamp":1772715600345,"change":0.06,"changeRate":0.003367,"amplitude":0},"delay":0,"changeRate":0.05381431105854525,"floatShares":5577143,"shares":16525644,"eps":-17.3,"marketStatus":"Pre-Mkt","change":0.91,"latestTime":"03-05 08:24:48 EST","open":16.82,"high":18.21,"low":16.53,"amount":4607174.943592,"amplitude":0.099349,"askPrice":21.15,"askSize":100,"bidPrice":16.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-17.3,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772721000000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":17.82,"preHourTrading":{"tag":"盘前","latestPrice":17.88,"preClose":17.82,"latestTime":"08:00 EST","volume":1,"amount":17.88,"timestamp":1772715600345,"change":0.06,"changeRate":0.003367,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":17.82,"preClose":17.82,"latestTime":"17:25 EST","volume":3078,"amount":54846.12,"timestamp":1772663111803,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.465173,"impliedVol":0.9429,"impliedVolPercentile":0.336},"requestUrl":"/m/hq/s/CTEV/tweets","defaultTab":"tweets","newsList":[{"id":"2616558396","title":"Claritev Corporation to Join Mizuho Virtual Healthcare Technology Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2616558396","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616558396?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:00","pubTimestamp":1772629227,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on March 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL9rg9fM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2616758123","title":"Claritev Corporation to Host 2026 Investor Day at New York Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2616758123","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616758123?lang=en_us&edition=fundamental","pubTime":"2026-03-04 02:58","pubTimestamp":1772564290,"startTime":"0","endTime":"0","summary":"Claritev Corporation to Host 2026 Investor Day at New York Stock Exchange               Claritev Corporation (NYSE: CTEV) will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stoc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDLkVwzS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2616361094","title":"Claritev EVP and Chief Digital Officer Michael Kim Acquires Claritev Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361094","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616361094?lang=en_us&edition=fundamental","pubTime":"2026-03-03 06:02","pubTimestamp":1772488954,"startTime":"0","endTime":"0","summary":"Michael Kim, EVP and Chief Digital Officer of Claritev Corporation, reported an acquisition of the company’s Class A common stock. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3DK6Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2616636132","title":"Claritev President, CEO and Executive Chair Travis Dalton Acquires Claritev Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616636132","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616636132?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:39","pubTimestamp":1772487588,"startTime":"0","endTime":"0","summary":"Dalton Travis, President, CEO and Executive Chair of Claritev Corporation, reported an acquisition of Class A common stock. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5hC5KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2616369041","title":"Claritev SVP and General Counsel Tara O'Neil Acquires Claritev Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616369041","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616369041?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:33","pubTimestamp":1772487204,"startTime":"0","endTime":"0","summary":"Tara O'Neil, SVP and General Counsel of Claritev Corporation, reported an acquisition of Class A common stock. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5TRK3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Claritev SVP and General Counsel Tara O'Neil Acquires Claritev Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2614086762","title":"Claritev price target lowered to $21 from $63 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2614086762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614086762?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:30","pubTimestamp":1772019039,"startTime":"0","endTime":"0","summary":"Citi analyst Daniel Grosslight lowered the firm’s price target on Claritev (CTEV) to $21 from $63 and keeps a Buy rating on the shares. Published f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-price-target-lowered-to-21-from-63-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-price-target-lowered-to-21-from-63-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2614074695","title":"Claritev Plunges on Disappointing 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2614074695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614074695?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:51","pubTimestamp":1771951860,"startTime":"0","endTime":"0","summary":"Claritev shares plunged after the company's 2026 outlook for revenue and adjusted earnings disappointed Wall Street investors.Shares fell 37% to $14.67 in midday Tuesday trading. The stock has fallen 80% over the past six months.The healthcare technology company on Monday reported a loss of $80.6 million, or $4.88 a share, compared with a loss of about $138 million, or $8.53 a share, in the year-ago period.Revenue rose to $246.6 million, up from $232.1 million a year prior. Analysts were expecting $241 million in revenue.For the current year, the company said it expects revenue between $980 million and $1 billion and adjusted earnings before interest, taxes, depreciation, and amortization of between $605 million and $615 million.Analysts were expecting revenue of $996.1 million and adjusted Ebitda of $620.8 million as of late January, prior to the earnings release.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2614745074","title":"Claritev Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2614745074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614745074?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:33","pubTimestamp":1771950780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 11:33 ET (16:33 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2613748304","title":"Claritev Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748304","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613748304?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:56","pubTimestamp":1771944960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CTEV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 09:56 ET (14:56 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791807156.HKD","CTEV","LU2361044949.HKD","IE00B19Z3581.USD","LU0070302665.USD","BK4207","LU1894683264.USD","LU0072461881.USD","BK4501","IE000M9KFDE8.USD","LU0417517546.SGD","LU0708994859.HKD","BK4585","LU1506573853.SGD","IE00B7SZLL34.SGD","LU0289960550.SGD","LU0211327993.USD","BK4588","LU1668664300.SGD","LU2461242641.AUD","LU0128525689.USD","LU0742534661.SGD","LU0211328371.USD","LU0320765489.SGD","LU0052756011.USD","LU0162691827.USD","LU0310800379.SGD","LU0130102774.USD","LU1267930573.SGD","LU0149725797.USD","LU0310799852.SGD","LU0787776722.HKD","LU1363072403.SGD","LU0868494617.USD","LU0251131958.USD","BK4559","LU0648001328.SGD","LU1894683348.USD","LU2236285917.USD","LU0267386448.USD","LU0251142724.SGD","LU1267930490.SGD","LU0310800965.SGD","LU0683600562.USD","LU1035773651.USD","LU2361044865.SGD","LU1074936037.SGD","IE0002270589.USD","LU1267930227.SGD","LU0208291251.USD"],"gpt_icon":0},{"id":"2613275571","title":"Claritev Corporation Releases Transcript of Fourth Quarter 2025 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2613275571","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613275571?lang=en_us&edition=fundamental","pubTime":"2026-02-24 07:26","pubTimestamp":1771889202,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief on February 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL3t2Q3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2613553897","title":"Claritev Corp reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2613553897","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613553897?lang=en_us&edition=fundamental","pubTime":"2026-02-24 06:55","pubTimestamp":1771887316,"startTime":"0","endTime":"0","summary":"Claritev Corp reports results for the quarter ended December 31 - Earnings SummaryClaritev Corp CTEV.N reported a quarterly adjusted loss of $4.88 per share for the quarter ended December 31, higher t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nL8N3ZJ2GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2613505730","title":"Claritev reports Q4 EPS ($4.88) vs ($8.53) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2613505730","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613505730?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:10","pubTimestamp":1771881047,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $246.6M, consensus $241.24M. “I am exceedingly proud of the work delivered by the Claritev (CTEV) team in 2025. This year marked...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-reports-q4-eps-4-88-vs-8-53-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-reports-q4-eps-4-88-vs-8-53-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2613737113","title":"Claritev Q4 revenue rises 6.2% to USD 246.55 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2613737113","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613737113?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:07","pubTimestamp":1771880856,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL888RRk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2613873719","title":"Claritev Q4 EPS $(4.88) Misses $(4.72) Estimate, Sales $246.554M Beat $241.025M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2613873719","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613873719?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:06","pubTimestamp":1771880803,"startTime":"0","endTime":"0","summary":"Claritev (NYSE:CTEV) reported quarterly losses of $(4.88) per share which missed the analyst consensus estimate of $(4.72) by 3.39 percent. This is a 5.43 percent increase over losses of $(5.16) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50798542/claritev-q4-eps-4-88-misses-4-72-estimate-sales-246-554m-beat-241-025m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Claritev Q4 EPS $(4.88) Misses $(4.72) Estimate, Sales $246.554M Beat $241.025M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2613730978","title":"Claritev Corp Outlook  FY Revenue $980 Mln to $1 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613730978?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:05","pubTimestamp":1771880701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA31KWWJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2613304567","title":"Claritev Corp - Board Approves $75 Mln Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2613304567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613304567?lang=en_us&edition=fundamental","pubTime":"2026-02-24 05:05","pubTimestamp":1771880701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA31KWWJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2613789071","title":"Claritev (CTEV) Gets a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2613789071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613789071?lang=en_us&edition=fundamental","pubTime":"2026-02-23 19:56","pubTimestamp":1771847764,"startTime":"0","endTime":"0","summary":"In a report released today, from Guggenheim reiterated a Buy rating on Claritev, with a price target of $43.00. Claritev has an analyst consensus o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/claritev-ctev-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/claritev-ctev-gets-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2612411283","title":"Discovery Health partners with Vira Health to launch Stella menopause app in South Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2612411283","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612411283?lang=en_us&edition=fundamental","pubTime":"2026-02-18 17:16","pubTimestamp":1771406197,"startTime":"0","endTime":"0","summary":"Discovery Health, part of Discovery Limited, has partnered with UK-based digital health company Vira Health to launch Stella, a clinically validated menopause support app, in South Africa. From 1 February, eligible Discovery Health Medical Scheme members aged 35 to 70 will receive complimentary access to Stella’s premium features for a year, including symptom tracking, personalised lifestyle plans, coaching and virtual GP consultations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Discovery Limited published the original content used to generate this news brief on February 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL6dbQfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2607087226","title":"Press Release: Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087226?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:02","pubTimestamp":1769691720,"startTime":"0","endTime":"0","summary":"Claritev Corporation  , a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time.Claritev is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by multiple data sources and over 40 years of claims experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose--built solutions that support all key players -- including pa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2607087620","title":"Claritev Corporation to Release Q4 and Fiscal Year 2025 Results and Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087620?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:00","pubTimestamp":1769691649,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation published the original content used to generate this news brief via Business Wire  on January 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL2mC2by:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTEV","BK4167"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.2024},{"period":"1month","weight":-0.3585},{"period":"3month","weight":-0.5177},{"period":"6month","weight":-0.7448},{"period":"1year","weight":-0.0743},{"period":"ytd","weight":-0.5832}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0148},{"period":"3month","weight":0.0011},{"period":"6month","weight":0.0585},{"period":"1year","weight":0.1877},{"period":"ytd","weight":0.0047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics, and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, dental, government and property and casualty markets. For more information, visit multiplan.com.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.061926},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.109417},{"month":3,"riseRate":0.5,"avgChangeRate":0.017475},{"month":4,"riseRate":0.4,"avgChangeRate":0.019306},{"month":5,"riseRate":0.833333,"avgChangeRate":0.209345},{"month":6,"riseRate":0.833333,"avgChangeRate":0.115629},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.035221},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.066869},{"month":9,"riseRate":0,"avgChangeRate":-0.132318},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.018931},{"month":11,"riseRate":0,"avgChangeRate":-0.185403},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131872}],"exchange":"NYSE","name":"Claritev Corporation","nameEN":"Claritev Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Claritev Corporation,CTEV,Claritev Corporation股票,Claritev Corporation股票老虎,Claritev Corporation股票老虎国际,Claritev Corporation行情,Claritev Corporation股票行情,Claritev Corporation股价,Claritev Corporation股市,Claritev Corporation股票价格,Claritev Corporation股票交易,Claritev Corporation股票购买,Claritev Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Claritev Corporation(CTEV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Claritev Corporation(CTEV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction